Lawrence Bloch

Biography

 Lawrence Bloch, M.D., J.D. is leader of Infinity. He joined the organization as CFO and boss business officer in 2012 and has assumed a key part in creating and executing the organization's corporate and budgetary procedures. Before joining Infinity in 2012, Dr. Bloch filled in as CEO of NeurAxon, Inc., an organization concentrated on creating cutting edge torment therapeutics, from 2007 to 2011. Beforehand, he filled in as boss business officer and CFO of NitroMed, Inc., bringing $150 million up in value and $20 million in wander obligation to help the business dispatch of BiDil®. From 1999 to 2004, he filled in as CFO and VP of business advancement of Applied Molecular Evolution, Inc., driving the organization's $101 million first sale of stock and $420 million merger with Eli Lilly and Company.

Research Interest

tumor growth inhibition